Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply

Richard E. Chaisson; Mohammad A. Chaudhary; Marcus B. Conde

doi:10.1016/S0140-6736(09)61190-9

Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply

Richard E. Chaisson, Mohammad A. Chaudhary, Marcus B. Conde

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2198-2199
Number of pages	2
Journal	The Lancet
Volume	373
Issue number	9682
DOIs	https://doi.org/10.1016/S0140-6736(09)61190-9
State	Published - 2009

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(09)61190-9

Cite this

@article{2bde93f0c4344369aef09a4c9224435d,

title = "Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply",

author = "Chaisson, {Richard E.} and Chaudhary, {Mohammad A.} and Conde, {Marcus B.}",

year = "2009",

doi = "10.1016/S0140-6736(09)61190-9",

language = "English (US)",

volume = "373",

pages = "2198--2199",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9682",

}

TY - JOUR

T1 - Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply

AU - Chaisson, Richard E.

AU - Chaudhary, Mohammad A.

AU - Conde, Marcus B.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=67649126268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649126268&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)61190-9

DO - 10.1016/S0140-6736(09)61190-9

M3 - Letter

C2 - 19560598

AN - SCOPUS:67649126268

SN - 0140-6736

VL - 373

SP - 2198

EP - 2199

JO - The Lancet

JF - The Lancet

IS - 9682

ER -

Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this